Position in AGIO
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$4,483,827
+$1,036,007 QoQ
Shares Held
132,540
+4.6% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Derivatives in AGIO
reported options exposure · as of Dec 31, 2020CallValue
$0
CallShares
0
PutValue
$541,625
PutShares
12,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. AGIO ranks #153 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in AGIO
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,483,827 | 132,540 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,447,820 | 126,665 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,746,513 | 242,813 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,952,418 | 118,834 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,857,110 | 131,642 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,700,509 | 234,343 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,073,282 | 114,186 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,990,759 | 69,359 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,996,677 | 170,885 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $41,288 | 1,854 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,494,725 | 60,393 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,047,478 | 72,298 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,971,629 | 85,835 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,585,746 | 92,085 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $414,584 | 14,660 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,754,421 | 79,135 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,335,070 | 45,863 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,094,919 | 185,425 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,334,453 | 93,921 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $687,000 | 12,466 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,360,042 | 26,337 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $52,212 | 1,205 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $541,625 | 12,500 | Put | Defined | 2021-02-11 | |
| 2020-09-30 | $7,350 | 210 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $437,500 | 12,500 | Put | Defined | 2020-11-12 | |
| 2020-06-30 | $150,118 | 2,807 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,774,000 | 50,000 | Call | Defined | 2020-05-01 | |
| 2020-03-31 | $329,964 | 9,300 | Put | Defined | 2020-05-01 | |
| 2020-03-31 | $125,670 | 3,542 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||